Note: All treatments are performed at our clinical facility in Houston
Understanding these phases can help you recognize progress and stay motivated, even when changes seem slow
Retatrutide is an investigational injectable triple agonist developed by Eli Lilly that simultaneously activates GIP, GLP-1, and glucagon receptors to produce complementary metabolic effects, including appetite suppression and potential increases in energy expenditure
The study also noted that B420 increased the abundance of Akkermansia muciniphila in participants' gut microbiota and increased fecal SCFA concentrations including butyric acid, which has been shown to stimulate GLP-1 secretion from intestinal L-cells
Ozempic is a brand-name drug manufactured by Novo Nordisk that contains semaglutide
Experiment With Food Pairings and Meal Timing Pairing carbohydrates with protein, fiber, or healthy fats may also help improve satiety and stabilize blood sugar after meals